As the US Centers for Medicare and Medicaid Services (CMS) has released the new prices for 15 drugs that have been added to ...
Novartis' Stein site will discontinue solid dose manufacturing in favour of sterile dose and cell & gene therapy production, ...
During the UK’s Autumn Budget, Rachel Reeves has unveiled further technology investments for the UK’s National Health Service ...
The approval marks the first for a targeted treatment in chronic spontaneous urticaria in Europe in over a decad ...
Otsuka Pharmaceutical has accelerated FDA approval for Voyxact to reduce proteinuria in adults with primary IgAN at disease ...
The path from discovery to lifechanging therapy shouldn't be blocked by manufacturing limitations. MasterControl offers ...
UNICEF and Gavi, the Vaccine Alliance, have announced a pricing deal to expand access to the R21/Matrix-M malaria vaccine.
TriLink BioTechnologies senior scientist Dr Cody Palumbo discusses the blockers to manufacturing mRNA-based gene editing therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback